Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma

Nam H. Dang*, Barbara Pro, Fredrick B. Hagemeister, Felipe Samaniego, Dan Jones, Barry I. Samuels, Maria A. Rodriguez, Andre Goy, Jorge E. Romaguera, Peter McLaughlin, Ann T. Tong, Francesco Turturro, Pamela L. Walker, Luis Fayad

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology